PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1584092
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1584092
Pericardiocentesis Procedures Market size was valued at USD 181.09 Million in 2023, expanding at a CAGR of 3.29% from 2024 to 2032.
Pericardiocentesis is a medical procedure used to remove excess fluid from the pericardium, the sac-like structure surrounding the heart. This fluid buildup, known as pericardial effusion, can put pressure on the heart, affecting its ability to function properly. In severe cases, it can lead to cardiac tamponade, a life-threatening condition where the heart cannot pump effectively due to the pressure.
Pericardiocentesis Procedures Market- Market Dynamics
Growing prevalence of cardiovascular disorders and rise in cancer therapies, early diagnosis is expected to propel market demand
The rising incidence of cardiovascular conditions such as pericarditis, heart failure, and pericardial effusion increases the demand for pericardiocentesis as a treatment option, which in turn is boosting market growth. Cardiac tamponade requires urgent pericardiocentesis for relief. Improved imaging technologies like ultrasound and echocardiography have made pericardiocentesis more accurate and safer, contributing to higher adoption rates. These imaging tools are essential for guiding the procedure.
Greater awareness of pericardial effusion and its complications has led to earlier detection and intervention. This, coupled with improved diagnostic capabilities, has driven the demand for procedures like pericardiocentesis. Certain cancer treatments, such as chemotherapy and radiation, can cause pericardial effusion as a side effect. This has led to increased demand for pericardiocentesis in cancer patients, especially those with advanced disease. Technological advancements in catheter-based therapies for pericardiocentesis, including improvements in needle design, catheter technology, and drainage systems, make the procedure more efficient and safer, boosting its adoption and supporting market growth.
Pericardiocentesis Procedures Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 3.29% over the forecast period (2024-2032)
Based on Indication segmentation, the malignancies segment was predicted to show maximum market share in the year 2023, owing to the high prevalence of cancer.
Based on Disease Type segmentation, the lung cancer segment was the leading Disease Type segment in 2023, due to the rise in cardiac disorders.
Based on End User segmentation, the hospital & clinics segment was the leading End User segment in 2023, due to the need for diagnosis of advanced cancer, tuberculosis, etc.
On the basis of region, North America was the leading revenue generator in 2023, due to the high prevalence of cardiovascular diseases.
Global Pericardiocentesis Procedures Market is segmented on the basis of Indication, Disease Type, End User, and Region.
The market is divided into five categories based on Indication: infections, malignancies, cardiac, inflammatory, and others. The malignancies segment dominates the market. Increasing incidence of metastatic tumors is mainly boosting segment growth.
The market is divided into four categories based on Disease Type: lung cancer, breast cancer, lymphoma, and others. The lung cancer segment dominates the market. The increasing incidence of cardiac arrests and lung diseases are fostering market demand.
The market is divided into three categories based on End User: hospital & clinics, cardiac centers, and others. The hospital & clinics segment dominates the market and is expected to maintain its high dominance during the forecast period. The prevalence of chronic immune diseases like lupus, rheumatoid arthritis, and scleroderma, etc. are fueling segment growth.
Pericardiocentesis Procedures Market- Geographical Insights
Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. In North America, the United States and Canada are major contributors, with the U.S. leading in terms of procedural volume and innovation. Europe is another significant market, driven by the aging population and rising incidence of cardiovascular diseases. In Asia Pacific, rising awareness and early diagnosis of pericardial effusion and cardiac diseases. China, Japan, and India are the key markets in this region, contributing to the growing demand for pericardiocentesis procedures.
The Pericardiocentesis Procedures Market is highly competitive, driven by key players like Medtronic, Boston Scientific, BD, and Cook Medical, who focus on technological innovation and product developments. Companies are offering customized pericardiocentesis kits tailored to the specific needs of healthcare providers and patient populations, ensuring that the procedure is as effective and efficient as possible. Companies are developing next-generation catheters and drainage systems that improve the safety, precision, and comfort of pericardiocentesis procedures.
In 2022, Teleflex Incorporated introduced specialized catheters and needle systems for draining fluid from the pericardial space.
In 2022, Cook Medical announced the launch of a variety of diagnostic and interventional devices, including pericardiocentesis kits and accessories.